Literature DB >> 19396814

Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.

Stefan Hajdu1, Andrea Lassnigg, Wolfgang Graninger, Alexander M Hirschl, Elisabeth Presterl.   

Abstract

Infection of medical implanted material is associated with considerable morbidity and costs. In the following work, we investigated the effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on biofilms formed by Staphylococcus epidermidis isolates causative for implant infection and catheter-associated bacteremia. Biofilms were studied using the static microtiter plate model and incubated with the antibiotics increasing the concentration from 1x to 128 x the minimal inhibitory concentration (MIC) of the respective isolate tested. To quantify the reduction of the biomass, the optical density ratio (ODr) of stained biofilms and the number of growing bacteria were determined. Incubation of the staphylococcal biofilms with the antibiotics decreased the biofilm ODr (at baseline = 1) for ceftriaxone (0.83 +/- 0.48) but minimally only for fosfomycin (0.96 +/- 0.64), daptomycin (1.05 +/- 0.59), tigecycline (1.18 +/- 0.66), and vancomycin (0.98 +/- 0.44) at exceedingly high concentrations of 128 x MIC. The significant reduction of the bacterial growth was not achieved for all antibiotics, not even at the highest concentrations tested. Using higher doses of the antibiotics may be of some value in the treatment of biofilm-associated infections, although effects are seen only at clinically unachievable doses. However, to eradicate the staphylococcal biofilm, additional measures like debridement and/or removal of the implant are needed. (c) 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396814     DOI: 10.1002/jor.20902

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  13 in total

1.  Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.

Authors:  Stefan Hajdu; Johannes Holinka; Sonja Reichmann; Alexander M Hirschl; Wolfgang Graninger; Elisabeth Presterl
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

Review 2.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 3.  Microbiology of the skin and the role of biofilms in infection.

Authors:  Steven L Percival; Charlotte Emanuel; Keith F Cutting; David W Williams
Journal:  Int Wound J       Date:  2011-10-05       Impact factor: 3.315

4.  Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.

Authors:  Jorge Parra-Ruiz; Celine Vidaillac; Warren E Rose; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

5.  Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.

Authors:  Elisabeth Presterl; Stefan Hajdu; Andrea M Lassnigg; Alexander M Hirschl; Johannes Holinka; Wolfgang Graninger
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

6.  Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.

Authors:  Fernanda Gomes; Pilar Teixeira; Howard Ceri; Rosário Oliveira
Journal:  Indian J Med Res       Date:  2012-04       Impact factor: 2.375

7.  Adjuvant antibiotic-loaded bone cement: Concerns with current use and research to make it work.

Authors:  Edward M Schwarz; Alex C McLaren; Thomas P Sculco; Barry Brause; Mathias Bostrom; Stephen L Kates; Javad Parvizi; Volker Alt; William V Arnold; Alberto Carli; Antonia F Chen; Hyonmin Choe; Débora C Coraça-Huber; Michael Cross; Michelle Ghert; Noreen Hickok; Jessica Amber Jennings; Manjari Joshi; Willem-Jan Metsemakers; Mark Ninomiya; Kohei Nishitani; Irvin Oh; Douglas Padgett; Benjamin Ricciardi; Kordo Saeed; Parham Sendi; Bryan Springer; Paul Stoodley; Joseph C Wenke
Journal:  J Orthop Res       Date:  2020-03-02       Impact factor: 3.102

8.  Biofilm-forming Staphylococcus epidermidis expressing vancomycin resistance early after adhesion to a metal surface.

Authors:  Toshiyuki Sakimura; Shiro Kajiyama; Shinji Adachi; Ko Chiba; Akihiko Yonekura; Masato Tomita; Hironobu Koseki; Takashi Miyamoto; Toshiyuki Tsurumoto; Makoto Osaki
Journal:  Biomed Res Int       Date:  2015-01-31       Impact factor: 3.411

9.  Farnesol in combination with N-acetylcysteine against Staphylococcus epidermidis planktonic and biofilm cells.

Authors:  Fernanda Gomes; Bruna Leite; Pilar Teixeira; Joana Azeredo; Rosário Oliveira
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

Review 10.  Periprosthetic joint infections: clinical and bench research.

Authors:  Laurence Legout; Eric Senneville
Journal:  ScientificWorldJournal       Date:  2013-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.